How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

High Level View of the Approach to Psoriatic Disease Treatment

Masterclasses in Dermatology

J. Merola

Assessment and Management of Ehlers-Danlos Syndrome (EDS)

APP2APP Virtual Lectures, Inc

M. Satterly

Practical Practice Pearls

Stephen Stone

Why Are Comorbidites Important in Dermatology? Hear The Answer From …

dermsquared

J. Del Rosso, J. M. Gelfand

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

The Microbiome and Psoriasis

International Psoriasis Council (IPC)

W. Liao

EADV 2024 Insights: High Induction Dosing in Psoriasis: KNOCKOUT Pha…

EADV 2024 Insights

A. Blauvelt

PsA for the Dermatologist

Masterclasses in Dermatology

J. Merola, A. Gottlieb

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Sex Matters: Gender Differences in PsA Outcomes & Management

RheumNow

L. Eder

Defining Severe Alopecia Areata and Treatment Updates

Abdulhadi Jfri

Tales of a Rash Whisperer: Untangling the Mystery of Adult Eczematou…

Jenny Murase

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

AAD 2024 Insights: Practical Practice Pearls

AAD 2024

S. Stone

2022 GRAPPA Treatment Recommendations

Laura Coates

GRAPPA 2024 Debate- Managing MSK Symptoms in PsO Patients: Who Shoul…

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

F. Proft

EADV 2024 Insights: New Topical Anti-Inflammatory Drugs

EADV 2024 Insights

N. Moftah

Panel Discussion on Hair, Scalp & Nail Dermatologic Conditions: How …

LivDerm

L. Stein Gold, A. W. Armstrong, D. J. Goldberg, A. Mcmichael